Bioelectronica Investors

Bioelectronica Introduction - SLAS2020

Investor Package

Please contact Jonathan Hull at jonathan@bioelectronica.com for more information on opportunities to invest in Bioelectronica.

About Us

Bioelectronica is a research-stage biotechnology company building intelligent, digital tools for drug discovery, cell screening and cell sorting. 

Our Team

A seasoned team of world-class technical talent in the areas of systems engineering, cell biology, and wet-chemistry, with a long history of working together to create value for our shareholders.

Our Story

After achieving entrepreneurial success in California's Silicon Valley and contributing to the next generation of DNA sequencing, Roger Chen founded Bioelectronica with co-founder Jonathan Hull. Biolectronica is building cutting-edge tools that use computer vision, biochemical reagents and consumer electronics to accelerate drug discovery. 

 

In January 2020, the Society for Laboratory Automation and Screening selected Bioelectronica’s Hypercell technology platform as the most innovative new product from around the globe that is “going above and beyond in their advancements of life sciences technologies." 

Contact Us

Bioelectronica Corporation HQ
6630 S McCarran Blvd
Suite B14
Reno, NV  89509 USA

 

+1 (775) 210-5140

Bioelectronica Corporation
Osterfeldstrasse 12-14
22529 Hamburg, Germany
 

+49 (40) 334 647 380

Investors 

Current investors and future opportunities to engage with Bioelectronica.

Careers

We are always interested in talented individuals, please send us your resume and cover letter if you are interested in joining our mission.

© 2018-2020 by Bioelectronica

Hypercell® is a registered trademark of Bioelectronica Corporation